Literature DB >> 14768039

Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production.

Laura Bilenki1, Jie Yang, Yijun Fan, Shuhe Wang, Xi Yang.   

Abstract

Although NKT cells have been found to be capable of modulating immune responses in several model systems, the role of NKT cells in allergy remains unclear. Using CD1 gene knockout (KO) mice, which lack NKT cells, we examined the function of NKT cells in the development of allergic inflammation induced by a common airborne human allergen, ragweed. The data showed that airway eosinophilia and mucus overproduction induced by ragweed were significantly reduced in CD1 KO mice, which was correlated with significantly lower allergen-driven IL-4 production and lower eotaxin responses in the airways of CD1 KO mice. Moreover, both ragweed-specific and total serum IgE levels in CD1 KO mice were significantly lower than those in control BALB/c mice. The reduced allergic reaction in CD1 KO mice is not due to intrinsic deficiency because they showed normal levels of immune cells and function. In addition, in vivo stimulation of NKT cells using their natural ligand, alpha-galactosylceramide, enhanced ragweed-induced airway eosinophilia, IL-4, and eotaxin production in control, but not CD1 KO mice. These data provide in vivo evidence for the involvement of NKT cells in the allergic mechanisms responsible for allergen-driven cytokine and chemokine production and airway inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14768039     DOI: 10.1002/eji.200324303

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  22 in total

Review 1.  Going both ways: immune regulation via CD1d-dependent NKT cells.

Authors:  Dale I Godfrey; Mitchell Kronenberg
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

2.  NKT cells are necessary for maximal expression of allergic conjunctivitis.

Authors:  Nancy J Reyes; Elizabeth Mayhew; Peter W Chen; Jerry Y Niederkorn
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

3.  Structure-guided design of an invariant natural killer T cell agonist for optimum protection from type 1 diabetes in non-obese diabetic mice.

Authors:  H J Blumenfeld; R Tohn; S M M Haeryfar; Y Liu; P B Savage; T L Delovitch
Journal:  Clin Exp Immunol       Date:  2011-10       Impact factor: 4.330

4.  Impact of bacteria on the phenotype, functions, and therapeutic activities of invariant NKT cells in mice.

Authors:  Sungjune Kim; Saif Lalani; Vrajesh V Parekh; Tiffaney L Vincent; Lan Wu; Luc Van Kaer
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 5.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

Review 6.  Recent advances in the role of NKT cells in allergic diseases and asthma.

Authors:  Philippe Stock; Omid Akbari
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

7.  Interleukin-4-dependent innate collaboration between iNKT cells and B-1 B cells controls adaptative contact sensitivity.

Authors:  Regis A Campos; Marian Szczepanik; Atsuko Itakura; Mariette Lisbonne; Neelendu Dey; Maria C Leite-de-Moraes; Philip W Askenase
Journal:  Immunology       Date:  2006-04       Impact factor: 7.397

8.  Glycolipid activation of invariant T cell receptor+ NK T cells is sufficient to induce airway hyperreactivity independent of conventional CD4+ T cells.

Authors:  Everett H Meyer; Sho Goya; Omid Akbari; Gerald J Berry; Paul B Savage; Mitchell Kronenberg; Toshinori Nakayama; Rosemarie H DeKruyff; Dale T Umetsu
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-14       Impact factor: 11.205

9.  Activation of invariant natural killer T cells in regional lymph nodes as new antigen-specific immunotherapy via induction of interleukin-21 and interferon-γ.

Authors:  T Sakurai; A Inamine; T Iinuma; U Funakoshi; S Yonekura; D Sakurai; T Hanazawa; T Nakayama; Y Ishii; Y Okamoto
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

Review 10.  Chronic inflammation and asthma.

Authors:  Jenna R Murdoch; Clare M Lloyd
Journal:  Mutat Res       Date:  2009-09-19       Impact factor: 2.433

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.